1. Home
  2. FATE vs NVCT Comparison

FATE vs NVCT Comparison

Compare FATE & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • NVCT
  • Stock Information
  • Founded
  • FATE 2007
  • NVCT 2020
  • Country
  • FATE United States
  • NVCT United States
  • Employees
  • FATE N/A
  • NVCT N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • NVCT Medicinal Chemicals and Botanical Products
  • Sector
  • FATE Health Care
  • NVCT Health Care
  • Exchange
  • FATE Nasdaq
  • NVCT Nasdaq
  • Market Cap
  • FATE 177.7M
  • NVCT 184.9M
  • IPO Year
  • FATE 2013
  • NVCT 2022
  • Fundamental
  • Price
  • FATE $1.14
  • NVCT $8.02
  • Analyst Decision
  • FATE Hold
  • NVCT Strong Buy
  • Analyst Count
  • FATE 7
  • NVCT 3
  • Target Price
  • FATE $3.83
  • NVCT $17.00
  • AVG Volume (30 Days)
  • FATE 1.7M
  • NVCT 180.3K
  • Earning Date
  • FATE 08-12-2025
  • NVCT 08-05-2025
  • Dividend Yield
  • FATE N/A
  • NVCT N/A
  • EPS Growth
  • FATE N/A
  • NVCT N/A
  • EPS
  • FATE N/A
  • NVCT N/A
  • Revenue
  • FATE $13,335,000.00
  • NVCT N/A
  • Revenue This Year
  • FATE N/A
  • NVCT N/A
  • Revenue Next Year
  • FATE N/A
  • NVCT N/A
  • P/E Ratio
  • FATE N/A
  • NVCT N/A
  • Revenue Growth
  • FATE 105.85
  • NVCT N/A
  • 52 Week Low
  • FATE $0.66
  • NVCT $4.44
  • 52 Week High
  • FATE $5.92
  • NVCT $11.80
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.69
  • NVCT 49.93
  • Support Level
  • FATE $1.05
  • NVCT $7.56
  • Resistance Level
  • FATE $1.18
  • NVCT $8.27
  • Average True Range (ATR)
  • FATE 0.08
  • NVCT 0.39
  • MACD
  • FATE -0.00
  • NVCT 0.08
  • Stochastic Oscillator
  • FATE 54.76
  • NVCT 89.52

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: